文献速递免疫规划妇幼与学校卫生

肯尼亚西部儿童和婴儿直接静脉接种辐射减毒全子孢子疟疾疫苗的可行性

Feasibility of direct venous inoculation of the radiation-attenuated Plasmodium falciparum whole sporozoite vaccine in children and infants in Siaya, western Kenya.
PubMed 文献 · Vaccine · 2020-05-19

该研究在肯尼亚西部农村医院评估了直接静脉接种(DVI)辐射减毒全子孢子疟疾疫苗(PfSPZ Vaccine)在儿童和婴儿中的可行性与耐受性。共511名参与者接受1222次注射,97.0%完成全量注射,婴儿单次DVI完成率从77.1%提升至92.8%,操作时间2.6-4.6分钟且年龄越小越长。结果表明由熟练注射者操作时DVI可行且耐受良好。

要点

  • DVI接种PfSPZ疫苗在5月龄至9岁儿童中总体可行,97.0%注射完成全量。
  • 婴儿单次DVI完成全量注射的比例从第一部分77.1%提高至第二部分92.8%。
  • 操作时间2.6-4.6分钟,年龄越小耗时越长;无哭闹比例随年龄降低而下降。

核心结论

  • 在肯尼亚西部农村医院由熟练注射者操作时,DVI接种PfSPZ疫苗在婴儿和儿童中可行且耐受良好。
  • 液氮蒸气相运输和储存简单高效。

研究设计与样本

  • 第一部分为年龄递减、剂量递增试验,纳入13月龄-5岁儿童和5-12月龄婴儿。
  • 第二部分为仅纳入婴儿的疫苗效力试验,使用第一部分最熟练的注射者。
  • 共511名参与者(36名5-9岁、65名13-59月龄、410名婴儿)启动1222次DVI注射(目标0.5 mL)。

主要发现

  • 1185/1222(97.0%)次接种完成全量注射,其中1083/1185(91.4%)经首次DVI即完成。
  • 474/511(92.8%)参与者仅接受全量注射,27/511(5.3%)至少接受一次部分注射(<0.5 mL),10/511(2.0%)未建立静脉通路。
  • 婴儿单次DVI完成全量注射率从第一部分77.1%提升至第二部分92.8%。
  • 无哭闹比例:5-9岁51/59(86.4%),13-59月龄25/86(29.1%),婴儿172/1067(16.1%)。
  • 平均操作时间2.6至4.6分钟,年龄越小时间越长。

临床怎么用

  • 在婴幼儿中开展静脉接种疫苗时,建议由熟练注射者操作并可借助静脉观察设备以提高成功率。
  • 需关注低龄儿童操作时间较长及哭闹比例较高的问题,做好操作准备与安抚。

局限性

  • 研究在肯尼亚西部农村医院开展,结果外推至其他环境需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PfSPZ Vaccine, composed of radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria. A critical issue for advancing vaccines that are administered intravenously is the ability to efficiently administer them across multiple age groups. As part of a pediatric safety, immunogenicity, and efficacy trial in western Kenya, we evaluated the feasibility and tolerability of DVI, including ease of venous access, injection time, and crying during the procedure across age groups. Part 1 was an age de-escalation, dose escalation trial in children aged 13 months-5 years and infants aged 5-12 months; part 2 was a vaccine efficacy trial including only infants, using the most skilled injectors from part 1. Injectors could use a vein viewer, if needed. A total of 1222 injections (target 0.5 mL) were initiated by DVI in 511 participants (36 were 5-9-year-olds, 65 were 13-59-month-olds, and 410 infants). The complete volume was injected in 1185/1222 (97.0%) vaccinations, 1083/1185 (91.4%) achieved with the first DVI. 474/511 (92.8%) participants received only complete injections, 27/511 (5.3%) received at least one partial injection (<0.5 mL), and in 10/511 (2.0%) venous access was not obtained. The rate of complete injections by single DVI for infants improved from 77.1% in part 1 to 92.8% in part 2. No crying occurred in 51/59 (86.4%) vaccinations in 5-9-year-olds, 25/86 (29.1%) vaccinations in 13-59-month-olds and 172/1067 (16.1%) vaccinations in infants. Mean administration time ranged from 2.6 to 4.6 minutes and was longer for younger age groups. These data show that vaccination by DVI was feasible and well tolerated in infants and children in this rural hospital in western Kenya, when performed by skilled injectors. We also report that shipping and storage in liquid nitrogen vapor phase was simple and efficient. (Clinicaltrials.gov NCT02687373).

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Oneko M, Cherop YR, Sang T, et al. Feasibility of direct venous inoculation of the radiation-attenuated Plasmodium falciparum whole sporozoite vaccine in children and infants in Siaya, western Kenya. Vaccine. 2020. PMID: 32444192. doi:10.1016/j.vaccine.2020.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。